Before the Open (Apr 3)

Good morning. Happy Monday. Hope you had a good weekend.
The Asian/Pacific markets closed up across-the-board. India, Indonesia and Hong Kong posted the biggest gains. Europe is currently mixed and little changed. Russia, Norway, Austria and Poland are leading; Spain is down. Futures in the States point towards mixed and flat open for the cash market.
—————
FREE 45-minute Webinar Thursday, April 6 -> click here to register
—————
The dollar is up. Oil and copper are up. Gold and silver are down. Bonds are up.
Last week the market posted a solid gain, but thanks to late-day selling on Friday, the S&P’s monthly winning streak was snapped.
The S&P is smack in the middle of its range; the Russell 2000 in the upper half of its range.
Long term the market looks great. Shorter term things are neutral and trying to turn up. The AD line has improved, and new highs at the NYSE expanded last week. It’s a start, but to support a rally attempt more improvement is needed.
I continue to like the market overall, but there’s no momentum in the near term.
Stock headlines from barchart.com…
Tesla (TSLA +0.14%) is up nearly 2% in pre-market trading after it said it delivered 25,000 vehicles in Q1, more than expectations of 24,200.
Helmerich & Payne (HP +0.06%) was upgraded to ‘Buy’ from ‘Neutral’ at Guggenheim Securities with a 12-month target price of $87.
AMC Entertainment Holdings (AMC +0.96%) was upgraded to ‘Outperform’ from ‘Market Perform’ at FBR Capital Markets.
Hilton Worldwide Holdings (HLT -0.53%) was downgraded to ‘Market Perform’ from ‘Outperform’ at Telsey Advisory Group.
SunTrust Bank (STI -1.39%) was upgraded to ‘Buy’ from ‘Hold’ at Jeffries with a price target of $63.
Under Armour (UA -0.38%) was downgraded to ‘Underperform’ from ‘Market Perform’ at FBR Capital Markets.
Dover (DOV +0.35%) was upgraded to ‘Overweight’ from ‘Equalweight’ at Morgan Stanley with a price target of $90.
FMC Corp (FMC +13.15%) was upgraded to ‘Buy’ from ‘Hold’ at Suntrust Robinson Humphrey with a price target of $82.
Mylan NV (MYL -1.52%) lost almost 1% in after-hours trading after it expanded a recall of EpiPens made by its manufacturing partner, Pfizer’s Meridian Medical, throughout the U.S., Europe, Asia and, North and South America.
Novocure LTB (NVCR +0.62%) surged over 20% in after-hours trading after it said a combination of tumor treating fields with nab-paclitaxel and gemcitabine improved survival rates of patients with advanced pancreatic cancer in a Phase 2 pilot study.
OM Asset Management Plc (OMAM +0.20%) was initiated with an ‘Outperform’ at Evercore ISI with a 12-month price target of $17.
SteadyMed (STDY +46.84%) jumped 11% in after-hours trading after it had already surged 47% in Friday’s session after it won a favorable ruling in a patent challenge against United Therapeutics.
Today’s Economic Calendar
9:45 PMI Manufacturing Index
10:00 ISM Manufacturing Index
10:00 Construction Spending
2:00 PM Gallup US Consumer Spending Measure
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY